Heparin and Pulmonary function test decreased - a phase IV clinical study of FDA data

Summary:

Pulmonary function test decreased is reported as a side effect among people who take Heparin (heparin sodium), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Ondansetron, and have Insomnia.

The phase IV clinical study analyzes which people have Pulmonary function test decreased when taking Heparin. It is created by eHealthMe based on reports of 91,860 people who have side effects when taking Heparin from the FDA, and is updated regularly.

What is Heparin?

Heparin has active ingredients of heparin sodium. It is often used in blood clots. eHealthMe is studying from 92,141 Heparin users. Check the latest studies of Heparin.

What is Pulmonary function test decreased?

Pulmonary function test decreased is found to be associated with 467 drugs and 500 conditions by eHealthMe. Check the latest studies of Pulmonary function test decreased.

On Jul, 26, 2026

91,860 people reported to have side effects when taking Heparin.
Among them, 24 people (0.03%) have Pulmonary function test decreased.

Could Heparin cause Pulmonary function test decreased?

Among these 24 people:

How long have people been on Heparin when they have Pulmonary function test decreased? *

What is the gender of people who have Pulmonary function test decreased when taking Heparin? *

female: 54.17 %
male: 45.83 %

What is the age of people who have Pulmonary function test decreased when taking Heparin? *

What are other drugs people take besides Heparin? *

Ondansetron: 6 people, 25.00%
Pulmozyme: 5 people, 20.83%
Vitamin D3: 5 people, 20.83%
Cefazolin: 5 people, 20.83%
Novolog: 4 people, 16.67%
Sulfamethoxazole And Trimethoprim: 4 people, 16.67%
Pantoprazole: 4 people, 16.67%
Meropenem: 4 people, 16.67%
Prograf: 3 people, 12.50%
Bactrim: 3 people, 12.50%

What are other side effects people have besides Pulmonary function test decreased? *

Dyspnea (difficult or laboured breathing): 8 people, 33.33%
Neutrophil Count Increased (excess than normal number of neutrophil a type of blood cell): 7 people, 29.17%
Blood Glucose Increased: 7 people, 29.17%
Head Injury: 6 people, 25.00%
Blood Urea Increased: 6 people, 25.00%
White Blood Cell Count Increased: 5 people, 20.83%
Nausea (feeling of having an urge to vomit): 5 people, 20.83%
Red Blood Cell Count Increased: 5 people, 20.83%
Cough: 5 people, 20.83%
Platelet Count Increased: 5 people, 20.83%

What are the existing conditions these people have? *

Pain: 5 people, 20.83%
Insomnia (sleeplessness): 5 people, 20.83%
Cystic Fibrosis Lung (fibrosis with cyst in the lung): 4 people, 16.67%
Cystic Fibrosis (disease of the secretary glands): 4 people, 16.67%
Type 2 Diabetes: 3 people, 12.50%
Arrhythmias (irregular heartbeat): 3 people, 12.50%
Myocardial Ischaemia (the blood flow through one or more of the blood vessels that lead to heart (coronary arteries) is decreased): 3 people, 12.50%
High Blood Pressure: 3 people, 12.50%
Dyspnea (difficult or laboured breathing): 3 people, 12.50%
Staphylococcal Bacteraemia (a bacterial infection of blood): 3 people, 12.50%

* Approximation only. Some reports may have incomplete information.

Do you take Heparin and have Pulmonary function test decreased?

- Check whether Pulmonary function test decreased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Heparin:

Heparin (92,141 reports)

Browse all side effects of Heparin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Pulmonary function test decreased:

Pulmonary function test decreased (467 drugs)

Browse all the conditions that are associated with Pulmonary function test decreased:

Pulmonary function test decreased (500 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on heparin sodium (the active ingredients of Heparin) and Heparin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.